23m
Investor's Business Daily on MSNAmid The Tumble, 3 Energy Stocks Lead The S&P 500 UpsideThree energy stocks lead gains for the S&P 500 as the market endures another tough week. Super Micro Computer, Axon, also ...
16h
Investor's Business Daily on MSNRyan Specialty, IBD Stock Of The Day, Eyes Buy Point After Finding Key SupportRyan Specialty boasts accelerating growth and rising relative strength. Ryan Specialty stock is nearing a buy point.
The Evidence Is Piling Up, and Here's What It Says. All It Takes Is $3,500 Invested in This High-Yield Dividend Stock to Generate $500 in Passive Income Over the Next 5 Years 1 Vanguard Index Fund ...
BALTIMORE, Feb. 28, 2025 (GLOBE NEWSWIRE) -- MarketWise, Inc. (NASDAQ: MKTW) (“MarketWise” or the “Company”), a leading multi-brand digital subscription ...
The deal with Lilly is a crucial boost for Organovo, which ended last year with just $1.2 million in cash and nearly $350 million in debt. Organovo FXR is a clinical drug program focused on farnesoid ...
Spyre Therapeutics' innovative combination therapy approach targets multiple inflammatory pathways. Learn why SYRE stock is a Buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results